Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Familial (FPAH)
|
276 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 1.000 | 32 | 2006 | 2019 | ||||
PARKINSON DISEASE, LATE-ONSET
|
76 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 1.000 | 19 | 2005 | 2019 | ||||
Movement Disorders
|
247 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.720 | 1.000 | 10 | 2004 | 2018 | ||||
Parkinson Disease, Familial, Type 1
|
27 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 1.000 | 10 | 2005 | 2015 | ||||
PARKINSON DISEASE 8 (disorder)
|
33 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.810 | 1.000 | 7 | 2005 | 2015 | ||||
Dyskinetic syndrome
|
42 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.050 | 1.000 | 5 | 2007 | 2018 | ||||
Mitochondrial abnormalities
|
20 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 1.000 | 4 | 2011 | 2017 | ||||
Motor symptoms
|
15 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||
Sense of smell impaired
|
12 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 1.000 | 4 | 2008 | 2018 | ||||
Depressed mood
|
269 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Depressive disorder
|
297 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Mental Depression
|
271 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Autosomal Dominant Parkinsonism
|
3 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2005 | 2007 | ||||
Bradykinesia
|
16 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||
Central neuroblastoma
|
231 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Childhood Neuroblastoma
|
231 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Cognition Disorders
|
47 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||
Frontotemporal Lobar Degeneration
|
54 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||
GRN-related frontotemporal dementia
|
20 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||
Hyperactive behavior
|
112 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||
Malignant neoplasm of skin
|
38 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Muscle Rigidity
|
25 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2007 | 2010 | ||||
Neuroblastoma
|
386 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Neurodegenerative Disorders
|
85 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2006 | 2014 | ||||
social stress
|
22 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2018 | 2018 |